New Technique Reveals Earliest Signs of Genetic Mutations [Yahoo! Finance]
PacBio and International Research Consortium CoLoRS Announce Release of First-Ever HiFi Long-Read Variant Database [Yahoo! Finance]
PacBio and International Research Consortium CoLoRS Announce Release of First-Ever HiFi Long-Read Variant Database
Pacific Biosciences of California, Inc. (NASDAQ: PACB) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $4.00 price target on the stock.
Pacific Biosciences: Navigating Rough Waters In Gene Sequencing Seas [Seeking Alpha]